Shares of Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) were down 5.1% on Tuesday . The stock traded as low as $8.33 and last traded at $8.45. Approximately 324,287 shares traded hands during trading, a decline of 41% from the average daily volume of 551,962 shares. The stock had previously closed at $8.90.
Cybin Price Performance
The firm has a 50 day moving average of $7.17 and a two-hundred day moving average of $8.29. The stock has a market cap of $1.24 billion and a PE ratio of -34.79.
About Cybin
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Recommended Stories
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
